西部证券股份有限公司 关于上海阿拉丁生化科技股份有限公司 2024年度持续督导工作现场检查报告 上海证券交易所： 根据《上海证券交易所上市公司自律监管指引第11号——持续督导》等有关法 律、法规的规定，西部证券股份有限公司（以下简称"保荐人"）作为上海阿拉丁 生化科技股份有限公司（以下简称"阿拉丁"、"公司"）持续督导阶段的保荐人， 于2025年10月14日对公司2024年度的规范运作情况进行了现场检查，现将现场检查 的有关情况报告如下： 一、本次现场检查的基本情况 二、现场检查的具体事项及意见 1 （一）公司治理和内部控制情况 核查情况：现场检查人员查阅了公司的公司章程、三会议事规则，收集了股东 大会、董事会和监事会的会议通知、决议和记录等资料，核对了公司相关公告，并 查阅了公司其他内控制度。 核查意见：经核查，2024年度，公司的章程和公司治理制度完备、合规，相关 制度得到有效执行，公司的董事、监事和高级管理人员能够按照有关规定的要求履 行责任，内部控制制度得到有效执行。 （一）保荐人：西部证券股份有限公司 （二）保荐代表人：滕晶、李晶 （三）现场检查时间：2025年10月14日 （四）现场检查人员：滕晶 ...

Core Viewpoint - Aladdin (688179.SH) experienced a decline of 3.96%, trading at 12.38 yuan, with a market capitalization of 4.1 billion yuan [1] Group 1: Shareholder Actions - The company announced that as of October 13, 2025, it received a notification from shareholder Jingzhen Culture regarding the completion of its share reduction plan [1] - Jingzhen Culture reduced its holdings by 2.4 million shares, which represents 0.7216% of the company's total share capital at the time the reduction plan was disclosed [1]

Core Viewpoint - Aladdin's stock has experienced a decline of 2.02% on October 14, with a current price of 12.63 CNY per share, reflecting a total market capitalization of 4.201 billion CNY. The company has seen a year-to-date stock price increase of 11.44%, but has faced recent declines over various trading periods [1][2]. Financial Performance - For the first half of 2025, Aladdin reported a revenue of 275 million CNY, representing a year-on-year growth of 15.45%. However, the net profit attributable to shareholders decreased by 39.79% to 28.4635 million CNY [2]. - Cumulative cash dividends since the A-share listing amount to 241 million CNY, with 150 million CNY distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 22.88% to 12,500, while the average circulating shares per person decreased by 2.42% to 26,670 shares [2]. - Among the top ten circulating shareholders, notable changes include a decrease in holdings by China Europe Medical Health Mixed A and an increase by China Europe Responsibility Investment Mixed A [3]. Company Overview - Aladdin Biochemical Technology Co., Ltd. was established on March 16, 2009, and went public on October 26, 2020. The company specializes in the research, development, production, and sales of reagents, with 96.96% of its revenue coming from scientific research reagents [1]. - The company operates within the basic chemical industry, specifically in the chemical products sector, and is associated with various concepts including ursodeoxycholic acid and synthetic biology [1].

Core Viewpoint - The announcement details the completion of a share reduction plan by a major shareholder of Shanghai Aladdin Biochemical Technology Co., Ltd, specifically the employee shareholding platform, Jingzhen Culture, which has reduced its holdings in the company. Group 1: Shareholder Holding Situation - Before the reduction plan, Jingzhen Culture held 9,781,190 shares, accounting for 2.94% of the company's total share capital, with shares obtained prior to the company's IPO and through capital reserve transfers [2][4]. Group 2: Reduction Plan Implementation Results - The reduction plan, disclosed on June 21, 2025, allowed Jingzhen Culture to reduce its holdings by up to 2,400,000 shares, representing no more than 0.7216% of the total share capital, with the reduction period set from July 14, 2025, to October 13, 2025 [3][6]. - As of the announcement date, Jingzhen Culture successfully reduced its holdings by 2,400,000 shares, which is exactly 0.7216% of the total share capital of 332,602,199 shares at the time of the plan disclosure [3][8].

| 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-063 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 股东减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 减持计划的实施结果情况 公司于 2025 年 6 月 21 日披露《关于公司股东减持股份计划公告》（公告编 号：2025-047），晶真文化拟通过集中竞价方式减持其所持有的公司股份合计不 超过 2,400,000 股（含本数），拟减持股份占公司总股本的比例不超过 0.7216%。 计划减持期限为自减持计划披露之日起 15 个交易日后的 3 个月内（即自 2025 年 7 月 14 日起至 2025 年 10 月 13 日）。减持价格按市场价格确定，若公司在上 述减持计划实施期间发生派发红利、送红股、转增股本、增发新股或配股等股本 除权、除息事项的，则上述减持计划将作相应调整。 2025 年 10 月 13 日，公 ...

Core Points - Aladdin (688179.SH) announced the completion of a share reduction plan by its shareholder, Jingzhen Culture, on October 13, 2025 [1] - Jingzhen Culture reduced its holdings by 2.4 million shares, which represents 0.7216% of the company's total share capital at the time of the reduction plan announcement [1]

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、可转债发行上市概况 （一）可转债发行上市情况 | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-061 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 可转债转股结果暨股份变动公告 经中国证券监督管理委员会证监许可〔2022〕72 号文同意注册，公司于 2022 年 3 月 15 日向不特定对象发行了 387.40 万张可转换公司债券，每张面值 100 元，发行总额 38,740.00 万元。 累计转股情况：上海阿拉丁生化科技股份有限公司（以下简称"公司"） 向不特定对象发行可转换公司债券"阿拉转债"自 2022 年 9 月 21 日开 始转股，截至 2025 年 9 月 30 日，"阿拉转债"累计有人民币 471,000 元已转换为公司股票，转股数量为 16,303 股，占"阿拉转债"转股前 公司已发行股份总额的 0.011537%。 未转股可转 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-062 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 重要内容提示： 会议召开时间：2025 年 10 月 20 日 （星期一） 09:00-10:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 10 月 13 日（星期一）至 10 月 17 日（星期五）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 aladdindmb@163.com 进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 上海阿拉丁生化科技股份有限公司（以下简称"公司"）已于 2025 年 8 ...

Core Points - The launch ceremony for the "Belt and Road Modern Agriculture and Cultural Tourism Industry Innovation Center" was held in Kashgar, Xinjiang, with participation from government representatives, experts, financial institutions, and media [1][6] - The project focuses on integrating global energy, industrial, and agricultural technologies to produce green agricultural products and seafood on a large scale [3][5] - The project will cover nearly 20,000 acres and include high-tech smart industrial greenhouses, a research base for industrial aquaculture, and various supporting facilities [3][5] Project Details - The project aims to consume approximately 20 billion kilowatt-hours of renewable energy annually, promoting sustainable development in the region [3] - The chairman of Aladdin Holdings emphasized the natural advantages of solar energy in the region, despite its arid conditions, and highlighted the strategic importance of developing industrial agriculture in Northwest China [5][6] - The project is expected to serve as a model for agricultural modernization and industrial upgrading for countries along the Belt and Road Initiative [6][10] Stakeholder Involvement - Key stakeholders, including local government officials and agricultural experts, expressed their commitment to supporting the project and ensuring its success [6][10] - The project aims to create a comprehensive industrial chain that includes planting, research, processing, trading, and cultural tourism [6][10] - The launch of three additional bases related to aquaculture, smart agricultural equipment, and cultural tourism was also announced during the ceremony [10]

上海阿拉丁生化科技股份有限公司（以下简称"公司"）第四届董事会、第 四届监事会任期将于 2025 年 10 月 9 日届满，根据新修订的《中华人民共和国公 司法》《上市公司章程指引》及《关于新<公司法>配套制度规则实施相关过渡期 安排》等要求，公司正在积极筹备配套管理制度修订及监事会改革等工作。 鉴于公司换届选举工作尚在积极筹备中，为确保各项工作的连续性和稳定性， 公司董事会、监事会的换届将适当延期，董事会各专门委员会委员及董事会聘任 的高级管理人员任期亦将相应顺延。 | 证券代码：688179 | 证券简称：阿拉丁 | 公告编号：2025-060 | | --- | --- | --- | | 转债代码：118006 | 转债简称：阿拉转债 | | 上海阿拉丁生化科技股份有限公司 关于董事会和监事会延期换届的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 上海阿拉丁生化科技股份有限公司 董事会 2025 年 9 月 30 日 在换届选举工作完成之前，公司第四届董事会及其专门委员会全体成员、第 四届监事会全体 ...